Follow
Elissa Ozanne
Elissa Ozanne
Associate Professor, University of Utah
Verified email at hsc.utah.edu
Title
Cited by
Cited by
Year
Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers
LJ Trevena, BJ Zikmund-Fisher, A Edwards, W Gaissmaier, M Galesic, ...
BMC medical informatics and decision making 13 (2), 1-15, 2013
4462013
Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters
G Elwyn, PJ Barr, SW Grande, R Thompson, T Walsh, EM Ozanne
Patient education and counseling 93 (1), 102-107, 2013
2482013
The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process
PJ Barr, R Thompson, T Walsh, SW Grande, EM Ozanne, G Elwyn
Journal of medical Internet research 16 (1), e3085, 2014
2062014
An approach to measuring the quality of breast cancer decisions
K Sepucha, E Ozanne, K Silvia, A Partridge, AG Mulley Jr
Patient education and counseling 65 (2), 261-269, 2007
1602007
Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients
D Braithwaite, CM Tammemagi, DH Moore, EM Ozanne, RA Hiatt, ...
International Journal of Cancer 124 (5), 1213-1219, 2009
1352009
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers A comparative effectiveness analysis
KP Lowry, JM Lee, CY Kong, PM McMahon, ME Gilmore, JE Cott Chubiz, ...
Cancer 118 (8), 2021-2030, 2012
1162012
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines
C O'Donoghue, M Eklund, EM Ozanne, LJ Esserman
Annals of internal medicine 160 (3), 145-153, 2014
1132014
Characterizing the impact of 25 years of DCIS treatment
EM Ozanne, Y Shieh, J Barnes, C Bouzan, ES Hwang, LJ Esserman
Breast cancer research and treatment 129 (1), 165-173, 2011
1072011
Biologic markers determine both the risk and the timing of recurrence in breast cancer
LJ Esserman, DH Moore, PJ Tsing, PW Chu, C Yau, E Ozanne, RE Chung, ...
Breast cancer research and treatment 129 (2), 607-616, 2011
1042011
Balancing the presentation of information and options in patient decision aids: an updated review
P Abhyankar, RJ Volk, J Blumenthal-Barby, P Bravo, A Buchholz, ...
BMC medical informatics and decision making 13 (2), 1-10, 2013
1012013
Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review
T Walsh, PJ Barr, R Thompson, E Ozanne, C O’Neill, G Elwyn
Bmj 348, 2014
852014
How to define and measure concordance between patients’ preferences and medical treatments: a systematic review of approaches and recommendations for standardization
K Sepucha, EM Ozanne
Patient education and counseling 78 (1), 12-23, 2010
822010
Development of a personalized decision aid for breast cancer risk reduction and management
EM Ozanne, R Howe, Z Omer, LJ Esserman
BMC medical informatics and decision making 14 (1), 1-8, 2014
762014
Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers
JM Lee, PM McMahon, CY Kong, DB Kopans, PD Ryan, EM Ozanne, ...
Radiology 254 (3), 793-800, 2010
752010
Implementing breast cancer decision aids in community sites: barriers and resources
KA Silvia, EM Ozanne, KR Sepucha
Health Expectations 11 (1), 46-53, 2008
742008
Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer
MD Alvarado, AJ Mohan, LJ Esserman, CC Park, BL Harrison, RJ Howe, ...
Annals of surgical oncology 20 (9), 2873-2880, 2013
702013
Impact of ductal carcinoma in situ terminology on patient treatment preferences
ZB Omer, ES Hwang, LJ Esserman, R Howe, EM Ozanne
JAMA internal medicine 173 (19), 1830-1831, 2013
692013
Which risk model to use? Clinical implications of the ACS MRI screening guidelines
EM Ozanne, B Drohan, P Bosinoff, A Semine, M Jellinek, C Cronin, ...
Cancer Epidemiology and Prevention Biomarkers 22 (1), 146-149, 2013
672013
Using Collabo RATE, a brief patient‐reported measure of shared decision making: Results from three clinical settings in the United States
RC Forcino, PJ Barr, AJ O'Malley, R Arend, MG Castaldo, EM Ozanne, ...
Health expectations 21 (1), 82-89, 2018
602018
Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome
EM Ozanne, A Loberg, S Hughes, C Lawrence, B Drohan, A Semine, ...
The breast journal 15 (2), 155-162, 2009
602009
The system can't perform the operation now. Try again later.
Articles 1–20